Whittier Trust Co. maintained its stake in HCP Inc. (NYSE:HCP) during the second quarter, Holdings Channel reports. The firm owned 7,847 shares of the real estate investment trust’s stock at the end of the second quarter. Whittier Trust Co.’s holdings in HCP were worth $278,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in HCP. Iowa State Bank bought a new stake in HCP during the second quarter worth approximately $145,000. Advisory Services Network LLC increased its stake in HCP by 29.2% in the second quarter. Advisory Services Network LLC now owns 4,252 shares of the real estate investment trust’s stock worth $150,000 after buying an additional 961 shares in the last quarter. Checchi Capital Advisers LLC increased its stake in HCP by 3.9% in the second quarter. Checchi Capital Advisers LLC now owns 5,288 shares of the real estate investment trust’s stock worth $187,000 after buying an additional 200 shares in the last quarter. Benin Management CORP bought a new stake in HCP during the second quarter worth approximately $203,000. Finally, Capital City Trust Co. FL bought a new stake in HCP during the second quarter worth approximately $204,000. Institutional investors and hedge funds own 90.96% of the company’s stock.
Shares of HCP Inc. (NYSE:HCP) traded down 0.63% during trading on Friday, hitting $36.24. The stock had a trading volume of 1,634,999 shares. The company’s 50 day moving average price is $38.03 and its 200 day moving average price is $36.15. The company’s market capitalization is $16.95 billion. HCP Inc. has a 52 week low of $25.11 and a 52 week high of $40.43.
HCP (NYSE:HCP) last issued its earnings results on Tuesday, August 9th. The real estate investment trust reported $0.74 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.04. HCP had a negative return on equity of 0.67% and a negative net margin of 2.52%. The business earned $662.20 million during the quarter, compared to analyst estimates of $631.25 million. During the same period in the previous year, the company posted $0.79 EPS. The firm’s revenue was up 9.0% compared to the same quarter last year. Analysts predict that HCP Inc. will post $2.82 earnings per share for the current year.
A number of equities research analysts recently commented on the company. Argus reiterated a “hold” rating on shares of HCP in a report on Sunday, September 18th. Wells Fargo & Co. restated a “hold” rating on shares of HCP in a report on Sunday, September 4th. Mizuho increased their price target on HCP from $32.00 to $37.00 and gave the stock a “neutral” rating in a report on Wednesday, August 10th. Zacks Investment Research upgraded HCP from a “hold” rating to a “buy” rating and set a $40.00 price target for the company in a report on Tuesday, July 5th. Finally, Citigroup Inc. increased their price target on HCP from $34.00 to $38.00 and gave the stock a “neutral” rating in a report on Wednesday, August 24th. Six research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $34.74.
In other HCP news, insider Darren A. Kowalske sold 2,250 shares of HCP stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $39.20, for a total transaction of $88,200.00. Following the completion of the transaction, the insider now owns 9,793 shares in the company, valued at approximately $383,885.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas D. Kirby sold 3,000 shares of HCP stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $40.24, for a total value of $120,720.00. The disclosure for this sale can be found here. Company insiders own 0.22% of the company’s stock.
HCP Company Profile
HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.